Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

The path to Crohn's disease: is mucosal pathology a secondary event?

Behr MA.

Inflamm Bowel Dis. 2010 May;16(5):896-902. doi: 10.1002/ibd.21171. Review.

PMID:
19924803
[PubMed - indexed for MEDLINE]
2.

Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.

Balfour Sartor R.

J Clin Gastroenterol. 2007 May-Jun;41 Suppl 1:S37-43. Review. Erratum in: J Clin Gastroenterol. 2007 Jul;41(6):637.

PMID:
17438417
[PubMed - indexed for MEDLINE]
3.

Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Sartor RB.

Gastroenterol Clin North Am. 1995 Sep;24(3):475-507. Review.

PMID:
8809232
[PubMed - indexed for MEDLINE]
4.

Etiology and pathogenesis of inflammatory bowel disease.

Schmidt C, Stallmach A.

Minerva Gastroenterol Dietol. 2005 Jun;51(2):127-45. Review.

PMID:
15990703
[PubMed - indexed for MEDLINE]
5.

Innate immune responses of epithelial cells following infection with bacterial pathogens.

Philpott DJ, Girardin SE, Sansonetti PJ.

Curr Opin Immunol. 2001 Aug;13(4):410-6. Review.

PMID:
11498296
[PubMed - indexed for MEDLINE]
6.

[Intestinal flora and Crohn's disease].

Desreumaux P, Colombel JF.

Ann Pharm Fr. 2003 Jul;61(4):276-81. Review. French.

PMID:
12843962
[PubMed - indexed for MEDLINE]
7.

Defects in mucosal immunity leading to Crohn's disease.

Cobrin GM, Abreu MT.

Immunol Rev. 2005 Aug;206:277-95. Review.

PMID:
16048555
[PubMed - indexed for MEDLINE]
8.

The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.

Caprilli R, Frieri G.

Dig Liver Dis. 2009 Feb;41(2):166-8. doi: 10.1016/j.dld.2008.09.012. Epub 2008 Nov 20. Review.

PMID:
19026604
[PubMed - indexed for MEDLINE]
9.

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.

Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I.

Gut. 1996 Mar;38(3):365-75.

PMID:
8675088
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Immunopathogenesis of Crohn's disease.

MacDonald TT, Di Sabatino A, Gordon JN.

JPEN J Parenter Enteral Nutr. 2005 Jul-Aug;29(4 Suppl):S118-24; discussion S124-5, S184-8. Review. Erratum in: JPEN J Parenter Enteral Nutr. 2006 Jan-Feb;30(1):table of contents. DiSabatino, Antonio [corrected to Di Sabatino, Antonio].

PMID:
15980273
[PubMed - indexed for MEDLINE]
11.

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

Korzenik JR, Dieckgraefe BK.

Dig Dis Sci. 2000 Jun;45(6):1121-9. Review.

PMID:
10877227
[PubMed - indexed for MEDLINE]
12.

Pathogenesis of Crohn's disease.

Hodgson HJ.

Baillieres Clin Gastroenterol. 1998 Mar;12(1):1-17. Review.

PMID:
9704153
[PubMed - indexed for MEDLINE]
13.

The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.

Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW.

J Med Microbiol. 2006 Aug;55(Pt 8):1141-9.

PMID:
16849736
[PubMed - indexed for MEDLINE]
Free Article
16.

The immunopathogenesis of Crohn's disease: a three-stage model.

Sewell GW, Marks DJ, Segal AW.

Curr Opin Immunol. 2009 Oct;21(5):506-13. doi: 10.1016/j.coi.2009.06.003. Epub 2009 Aug 8. Review.

PMID:
19665880
[PubMed - indexed for MEDLINE]
17.

Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II).

Chandran P, Satthaporn S, Robins A, Eremin O.

Surgeon. 2003 Jun;1(3):125-36. Review.

PMID:
15570747
[PubMed - indexed for MEDLINE]
18.

A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.

Wehkamp J, Stange EF.

Ann N Y Acad Sci. 2006 Aug;1072:321-31. Review.

PMID:
17057212
[PubMed - indexed for MEDLINE]
19.

Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease.

Olbe L.

Scand J Gastroenterol. 2008;43(2):234-41. Review.

PMID:
17918000
[PubMed - indexed for MEDLINE]
20.

Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

Ricciardelli I, Lindley KJ, Londei M, Quaratino S.

Immunology. 2008 Oct;125(2):178-83. doi: 10.1111/j.1365-2567.2008.02839.x. Epub 2008 Apr 16.

PMID:
18422560
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk